In vitro grafting of hepatic spheroids and organoids on a microfluidic vascular bed

Abstract

With recent progress in modeling liver organogenesis and regeneration, the lack of vasculature is becoming the bottleneck in progressing our ability to model human hepatic tissues in vitro. Here, we introduce a platform for routine grafting of liver and other tissues on an in vitro grown microvascular bed. The platform consists of 64 microfluidic chips patterned underneath a 384-well microtiter plate. Each chip allows the formation of a microvascular bed between two main lateral vessels by inducing angiogenesis. Chips consist of an open-top microfluidic chamber, which enables addition of a target tissue by manual or robotic pipetting. Upon grafting a liver microtissue, the microvascular bed undergoes anastomosis, resulting in a stable, perfusable vascular network. Interactions with vasculature were found in spheroids and organoids upon 7 days of co-culture with space of Disse-like architecture in between hepatocytes and endothelium. Veno-occlusive disease was induced by azathioprine exposure, leading to impeded perfusion of the vascularized spheroid. The platform holds the potential to replace animals with an in vitro alternative for routine grafting of spheroids, organoids, or (patient-derived) explants.

Interstitial Flow Promotes the Formation of Functional Microvascular Networks In Vitro through Upregulation of Matrix Metalloproteinase‐2

“…Moreover, MVNs are often engineered to study interactions with other physiological systems, such as neural or muscular tissues, or used as a platform to host various developing organoids. [32][33][34][35][36] In those multiculture systems, the choice of hydrogel scaffold and composition of culture medium must be carefully designed to support the development and growth of all the cellular com ponents. With our methodology, MVN development in multi culture systems could be substantially improved by employing IF to boost vasculogenesis, significantly broadening the applica tion of selforganized MVNs.…”

Novel kinome profiling technology reveals drug treatment is patient and 2D/3D model dependent in glioblastoma

“…Drug screenings in 2D and 3D glioblastoma cell cultures have already been investigated ( 61 ). However, our approach provides additional relevant information through the application of organ-on-a-chip system, which is a technology that can be exploited to recreate multiple environmental interactions, and the direct read-out of kinase activity ( 25 , 62 ). Due to the lack of replicates and low amounts of proteins for 3D OMS, we limited our analysis on ErbB signaling kinases that were identified in common with the 2D cell cultures.…”

Novel kinome profiling technology reveals drug treatment is patient and 2D/3D model dependent in GBM

“…Drug screenings in 2D and 3D GBM cell cultures have already been investigated (55). However, our approach provides additional relevant information through the application of organ-on-a-chip system, which is a technology that can be exploited to recreate multiple environmental interactions, and the direct read-out of kinase activity (25, 56). Due to the lack of replicates and low amounts of proteins for 3D OMS, we limited our analysis on ErbB signaling kinases that were identified in common between the 2D cell cultures.…”